Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study.

Bélanger SA, Vanasse M, Spahis S, Sylvestre MP, Lippé S, L'heureux F, Ghadirian P, Vanasse CM, Levy E.

Paediatr Child Health. 2009 Feb;14(2):89-98.

2.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
3.

Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder.

Burgess JR, Stevens L, Zhang W, Peck L.

Am J Clin Nutr. 2000 Jan;71(1 Suppl):327S-30S. Review.

5.

Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review.

Raz R, Gabis L.

Dev Med Child Neurol. 2009 Aug;51(8):580-92. doi: 10.1111/j.1469-8749.2009.03351.x. Epub 2009 Jun 22. Review.

6.

Polyunsaturated fatty acid status in attention deficit hyperactivity disorder, depression, and Alzheimer's disease: towards an omega-3 index for mental health?

Milte CM, Sinn N, Howe PR.

Nutr Rev. 2009 Oct;67(10):573-90. doi: 10.1111/j.1753-4887.2009.00229.x. Review.

PMID:
19785689

Supplemental Content

Support Center